Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Elekta AB (publ)
  6. Company
    EKTA B   SE0000163628

ELEKTA AB (PUBL)

(EKTA B)
  Report
Real-time Estimate Cboe Europe  -  04:21:20 2023-01-30 am EST
75.22 SEK   -0.29%
2022Transcript : Elekta AB - Special Call
CI
2022Transcript : Elekta AB - Special Call
CI
2022Elekta Says First Pancreatic Cancer Patient Treated Using Unity MR-Linac
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Elekta AB (publ)
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).

Number of employees : 4 826 people.
Sales per Business
20212022Delta
Oncology Information and Radiotherapy8 175.0059.4%8 652.0059.5% +5.83%
Services5 588.0040.6%5 896.0040.5% +5.51%
SEK in Million
Sales per region
20212022Delta
United States3 147.0022.9%3 228.0022.2% +2.57%
Europe, Middle East and Africa2 227.0016.2%2 413.0016.6% +8.35%
China2 221.0016.1%2 314.0015.9% +4.19%
Japan926.006.7%953.006.6% +2.92%
Asia Pacific879.006.4%879.006% 0%
Germany650.004.7%741.005.1% +14%
Italy697.005.1%594.004.1% -14.78%
Americas492.003.6%574.003.9% +16.67%
France445.003.2%487.003.3% +9.44%
India397.002.9%482.003.3% +21.41%
Canada249.001.8%452.003.1% +81.53%
United Kingdom389.002.8%449.003.1% +15.42%
Australia312.002.3%344.002.4% +10.26%
Netherlands304.002.2%339.002.3% +11.51%
Spain382.002.8%260.001.8% -31.94%
Sweden46.000.3%38.000.3% -17.39%
SEK in Million
Managers
Name Title Age Since
Gustaf Salford President & Chief Executive Officer 45 2020
Tobias Hńggl÷v Chief Financial Officer 44 2022
Steven Wort Chief Operating Officer 59 2017
Cecilia Ketels Head-Investor Relations - -
Jonas Bolander Secretary, Executive VP & General Counsel 56 -
Gustaf Sverker Littorin Executive Vice President 67 -
John LaprÚ President-Brachy & Neuro Solutions 58 -
Maurits Wolleswinkel Chief Product Officer 51 -
Kevin Brown Global Vice President-Scientific Research - -
Eva Karin Svenske-Nyberg Executive Vice President-Human Resources 56 2017
Members of the board
Name Title Age Since
Laurent Leksell Chairman 70 2013
Jane M. Birgitta G÷ransson Independent Director 65 2005
Jan Joel Aron Secher Independent Director 65 2010
Wolfgang Reim, Dr. Independent Director 66 2011
Johan Malmquist Independent Director 61 2015
Caroline Leksell Cooke Independent Director 41 2017
Cecilia Wikstr÷m Director 57 2018
Kelly J. Londy Director 56 2022
Birgitta Stymne G÷ransson Director - -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 10 14,250,000 0 0.0% 0 0.0% 93.9%
Stock B 1 368,587,640 359,345,727 97.5% 1,485,289 0.4%
Shareholders
NameEquities%
Fjńrde AP-fonden 33,680,795 9.14%
Nordea Investment Management AB 18,879,111 5.12%
SEB Investment Management AB 15,521,171 4.21%
Schroder Investment Management Ltd. 13,669,720 3.71%
AMF Fonder AB 12,826,022 3.48%
T. Rowe Price Associates, Inc. (Investment Management) 12,290,929 3.33%
The Vanguard Group, Inc. 10,787,675 2.93%
Lannebo Fonder AB 10,742,787 2.91%
Swedbank Robur Fonder AB 10,452,128 2.84%
Handelsbanken Fonder AB 9,220,363 2.50%
Holdings
NameEquities%Valuation
ELEKTA AB (PUBL) (EKTA B) 1,485,289 0.40% 8,952,074 USD
Company contact information
Elekta AB
Kungstensgatan 18
Stockholm, Sodermanland 103 93

Phone : +46.8.587.254.00
Fax : +46.8.587.255.00
Web : http://www.elekta.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Elekta AB (publ)